Design; Synthesis and Antihypertensive activity of 4'-(2-{2-[(2-chlorobenzylidene)-amino]-phenyl}-5-nitro-benzoimidazol-1-ylmethyl)] biphenyl-2-carboxylic acid

Authors

  • M. C. Sharma Department of Pharmaceutical Sciences Dr.Hari Singh Gour University Sagar (M.P) 470003 India
  • D.V.Kohli Department of Pharmaceutical Sciences Dr.Hari Singh Gour University Sagar (M.P) 470003 India
  • Smita Sharma Department of Chemistry Yadhunath Mahavidyalya Bhind (M.P) 477001 India

Keywords:

Benzimidazoles, biphenyl-2-carboxylic acid, angiotensin II, hypertension

Abstract

In the present study, a series of 4`-(2-{2-[(2-chloro-benzylidene)- amino]-phenyl}-5-nitro-benzoimidazol-1-ylmethyl)] biphenyl-2- carboxylic acid derivatives are synthesized by A one-step coupling of substituted benzimidazoles with biphenyl carboxylic moiety mediated by potassium carbonate is described. The biphenyl carboxylic moiety was prepared from 9-H-fluorenone and substituted benzimidazoles were synthesized from ophenylenediamine with anthranilic acid.

References

Goodman G, The Pharmacological Basis

of Therapeutics, 7th Ed., McGraw-Hill,

New York ed., 1985, pp.639–659.

Juillerat J.L, Celerier J, Chapuis B.C,

Nguyen G, Wostle W, Maerki H.P, Janzer

R.C. Rennin and angiotensinogen

expression and functions in growth and

apoptosis of human glioblastoma. Br J

Cancer 2004; 90: 1059-1068.

FogartyD.J, Sanchez-Gomez M.V, Matute

C. Multiple angiotensin receptor subtype

in normal and tumor astrocyte in vitro.

Glia 2002;39: 304-314.

Tiziano T, Vincenzo C, Simona R,

Adriano M. Proposal of a new binding

orientation for non-peptide ATI

antagonists: Homology modeling, docking

and three dimensional quantitative

structure-activity relationship analysis. J

Med Chem 2006;49: 4305-4316.

Wong PC, Barnes TB, Chiu AT. Losartan

(DuP 753), an Orally Active Nonpeptide

Angiotensin II Receptor Antagonist.

Cardiovasc Drug Rev 1991; 9: 317-319.

Bali A, Bansal Y, Sugumaran M, Saggu

J.S, Balakumar P, Kaur G, Bansal G,

Sharma A, Singh M. Design, synthesis and

evaluation of novelly substituted

benzimidazole compounds as angiotensin

II receptor antagonists. Bioorg Med Chem

Lett 2005;15,3962-3965.

Jat R.K,Jat J.L, Pathak D.P.Synthesis of

Benzimidazole Derivatives: As Antihypertensive Agents.E Journal of

Chemistry 2006;3:(13), 278-285.

Dhvanit I. S, Sharma M, Bansal Y,Bansal

G, M. Singh. Angiotensin II AT1 receptor

antagonists: Design, synthesis and

evaluation of substituted carboxamido

benzimidazole derivatives European

Journal of Medicinal Chemistry 2008;43,

-1812.

Badyal D.K, Lata H, Dadhich A.P.Indian J

of Pharmacology 2003; 35(66), 349-362.

Bunag R.D, McCubbin J.W, Page I.H.

Lack of correlation between direct and

indirect measurements of arterial pressure

in unanaesthetized rats. Cardiovasc Res

;5(1): 24-31.

Gupta S.K.Drug Screening methods,

Jaypee Brothers Medical Publisher, New

Delhi,2004; pp 236-246.

Shreenivas M.T, Chetan B.P, Bhat A.R,

Synthesis and Pharmacological Evaluation

of Certain Schiff Bases and Thiazoldine

Derivatives as AT1 Angiotension-II (AII)

Receptor Antagonists. Journal of

Pharmaceutical Science and Technology

; 1 (2), 88-94.

Fieser M, Fieser L. Reagents for organic

synthesis 1969; 2, pp. 389.

Saggu J.S, Sharma R,Dureja H,Kumar V.

Benzimidazoles with biphenyls: Synthesis

of 5-substituted-2-npropyl- 1-[(2’-

carboxybiphenyl-4-yl-) methyl]

benzimidazoles. J Indian Inst Sci 2002;82,

–182.

Downloads

Published

09/30/2010

Issue

Section

Original Research Articles